Holen Sie sich die Stockscreener-App
48.86
3.89%
1.83
Schlusskurs vom Vortag:
$47.03
Offen:
$47.11
24-Stunden-Volumen:
547.44K
Relative Volume:
1.17
Marktkapitalisierung:
$1.54B
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
41.06
EPS:
1.19
Netto-Cashflow:
$274.29M
1W Leistung:
+2.11%
1M Leistung:
+12.24%
6M Leistung:
+60.88%
1J Leistung:
+62.06%
1-Tages-Spanne:
$46.15
$48.94
1-Wochen-Bereich:
$46.15
$49.09
52-Wochen-Spanne:
$23.23
$49.09
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Vergleichen Sie COLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
48.86 | 1.49B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-01-10 | Hochstufung | Needham | Hold → Buy |
| 2024-07-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-05-10 | Herabstufung | Needham | Buy → Hold |
| 2024-05-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-25 | Bestätigt | Needham | Buy |
| 2023-05-02 | Fortgesetzt | Jefferies | Buy |
| 2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-14 | Eingeleitet | BWS Financial | Sell |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-02-19 | Fortgesetzt | Jefferies | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-04-12 | Fortgesetzt | Janney | Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-02-07 | Bestätigt | Needham | Buy |
| 2017-12-05 | Bestätigt | Needham | Buy |
| 2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
| 2015-06-01 | Eingeleitet | Jefferies | Buy |
| 2015-06-01 | Eingeleitet | Needham | Buy |
| 2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Collegium pharmaceutical EVP Dreyer sells $847k in stock - Investing.com India
Collegium Pharmaceutical Insider Sold Shares Worth $847,855, According to a Recent SEC Filing - marketscreener.com
Does Zacks’ Value Spotlight on Collegium (COLL) Reframe Its Cash-Flow Story for Investors? - simplywall.st
Barclays Initiates Collegium Pharmaceutical at Overweight With $58 Price Target - marketscreener.com
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month HighWhat's Next? - MarketBeat
Collegium (NASDAQ:COLL) Nasdaq Biggest Companies Pharma Activity - Kalkine Media
Collegium Pharmaceutical (COLL): Revisiting Valuation After Fresh Coverage and Ongoing Earnings Outperformance - Yahoo Finance
Collegium Pharmaceutical (COLL): Assessing Valuation After Earnings Beats, Strong Zacks Rating and Value Investor Interest - simplywall.st
Can Collegium Pharmaceutical Inc. stock withstand economic slowdown2025 Sector Review & Safe Investment Capital Preservation Plans - Newser
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now? - sharewise.com
Can Collegium Pharmaceutical Inc. (354) stock hit consensus price targetsJuly 2025 News Drivers & Consistent Growth Stock Picks - Newser
What RSI levels show for Collegium Pharmaceutical Inc. (354) stockEarnings Trend Report & Weekly High Return Forecasts - Newser
How Collegium Pharmaceutical Inc. stock responds to policy changesWeekly Trade Recap & Real-Time Stock Movement Alerts - Newser
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 12-Month HighStill a Buy? - MarketBeat
Collegium Pharmaceutical, Inc. (COLL) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Will Collegium Pharmaceutical Inc. (354) stock justify high valuationQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser
Will Collegium Pharmaceutical Inc. (354) stock benefit from commodity supercycle2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser
Will Collegium Pharmaceutical Inc. (354) stock sustain uptrend momentum2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Collegium Pharmaceutical stock hits all-time high at 48.19 USD By Investing.com - Investing.com Australia
Collegium Pharmaceutical stock hits all-time high at 48.19 USD - Investing.com
Loomis Sayles & Co. L P Increases Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Will Collegium Pharmaceutical Inc. (354) stock hit analyst forecastsWeekly Stock Report & AI Enhanced Trade Execution Alerts - Newser
Can Collegium Pharmaceutical Inc. (354) stock withstand sector downturnsPortfolio Risk Report & AI Driven Price Forecasts - Newser
Why Collegium Pharmaceutical Inc. (354) stock is a strong analyst pickTrade Volume Report & Real-Time Volume Surge Alerts - Newser
Ballast Asset Management LP Makes New Investment in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Geode Capital Management LLC Increases Stock Holdings in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - Yahoo Finance
Collegium Pharmaceutical Reports Record Q3 2025 Results - MSN
Collegium Pharmaceutical (COLL): Exploring Valuation After Recent Share Price Surge - simplywall.st
Precision Trading with Collegium Pharmaceutical Inc. (COLL) Risk Zones - news.stocktradersdaily.com
Is Collegium Pharmaceutical Inc 354 a good long term investmentEarnings Per Share Trends & Low Risk Portfolio Growth - earlytimes.in
Why Investors Shouldn't Be Surprised By Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 26% Share Price Surge - 富途牛牛
Free cash flow per share of Collegium Pharmaceutical, Inc. – TRADEGATE:354 - TradingView
Collegium Pharmaceutical collaborates with Paris Hilton - MSN
Brandywine Global Investment Management LLC Increases Stake in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Why 2025 is a Dynamic and Transformative Year for Collegium - MSN
Hillsdale Investment Management Inc. Has $5.26 Million Stock Holdings in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Has Analyst Spotlight on COLL Revealed a Turning Point in Its Competitive Advantage? - simplywall.st
Why Collegium Pharmaceutical Inc. stock is popular among millennialsPortfolio Gains Summary & Free Safe Entry Trade Signal Reports - newser.com
Is Collegium Pharmaceutical Inc. (354) stock a safe buy pre earningsQuarterly Risk Review & Safe Capital Growth Trade Ideas - newser.com
Bank of New York Mellon Corp Grows Stake in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Is Collegium Pharmaceutical Inc. (354) stock in buy zone after pullback2025 Price Targets & AI Optimized Trading Strategy Guides - newser.com
Collegium (COLL) Raises 2025 Revenue Guidance—Is Profitability Momentum Built to Last? - Yahoo Finance
Intech Investment Management LLC Purchases 36,767 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.87%
4.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):